RA also enhanced the efficacy of gemcitabine through the downregulation of multidrug resistance-associated protein 4 (MRP-4) and MRP-5 in Panc-1 pancreatic cancer cells [117]. Here, ABCC4 is linked to pancreatic neoplasm.